Diagnosis and treatment of premenstrual dysphoric disorder

International Journal of Psychiatry in Clinical Practice

Volumn 1, Issue 3, 1997, Pages 149-156

  Davis, Lori ^a   Yonkers, Kimberly A ^a,b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS AT DALLAS   (United States)

Author keywords

Antidepressant treatment; Premenstrual dysphoric disorder; Premenstrual syndrome; Psychiatric diagnosis; Women

Indexed keywords

EID: 0006831515     PISSN: 13651501     EISSN: None     Source Type: Journal    
DOI: 10.3109/13651509709024721     Document Type: Article

References (86)

1. American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders. Fourth edition (DSM-IV). American Psychiatric Association, Washington, DC.
2. Gise LH, Lebovits AH, Paddison PL, Strain JJ (1990) Issues in the identification of premenstrual syndromes. J Nerv Ment Dis 178: 228-234.
3. Freeman EW, Rickles K, Schweizer E, Ting T (1995) Relationships between age and symptom severity among women seeking medical treatment for premenstrual symptoms. Psychol Med 25: 309-315.
4. Rubinow DR, Roy-Byme P, Hoban MC et al (1984) Prospective assessment of menstrually related mood disorders. Am J Psychiatry 141: 684-686.
5. Endicott J, Nee J, Cohne J, Halbreich U (1986) Premenstrual changes: Patterns and correlates of daily ratings. J Affect Disord 10: 127-135.
6. Moos RH (1968) The development of a menstrual distress questionnaire. Psychosom Med 30: 853-867.
7. Freeman EW, Sondheimer S, Weinbaum PJ, Rickels K (1985) Evaluating premenstrual symptoms in medical practice. Obstet Gynecol 65: 500-505.
8. Yonkers KA (1997) The association between premenstrual dysphoric disorder and other mood disorders. J Clin Psychiatry, in press.
9. Kendler KS, Silberg JL, Neale MC et al (1992) Genetic and environmental factors in the etiology of menstrual, premenstrual and neurotic symptoms: A population-based twin study. Psychol Med 22: 85-100.
10. Schmidt PJ, Nieman LK, Grover GN et al (1991) Lack of effect of induced menses on symptoms in women with premenstrual syndrome. N Engl J Med 324: 1174-1179.
11. Metcalf MG, Braiden V, Livesey JH, Wells JE (1992) The premenstrual syndrome: Amelioration of symptoms after hysterectomy. J Psychosom Res 36: 568-584.
12. Roca CA, Schmidt PJ, Bloch M, Rubinow DR (1996) Implications of endocrine studies of premenstrual syndrome. Psychiatr Ann 16: 576-580.
13. MacDonald PC, Dombroski RA, Casey ML (1991) Recurrent secretion of progesterone in large amounts: An endocrine/ metabolic disorder unique to young women? Endocr Rev 12: 372-401.
14. Schmidt PJ, Purdy RJ, Moore PH et al (1994) Circulating levels of anxiolytic steroids in the luteal phase in women with premenstrual syndrome and in control subjects. J Clin Endocrinol Metab 79: 1256-1260.
15. Halbreich U, Asnis G, Ross D, Endicott J (1981) Amphetamine-induced dysphoria in postmenopausal women. Er J Psychiatry 138: 470-473.
16. Facchinetti F, Genazzini AD, Martignoni E et al (1990) Neuroendocrine correlates of premenstrual syndrome: Changes in the pulsatile pattern of plasma LH. Psychoneuroendocrinol 15: 269-277.
17. Hamilton JA, Gallant SA (1988) Premenstrual symptom changes and plasma B-endorphin/B-lipotropin throughout the menstrual cycle. Psychoneuroendocrinol 13: 505-514.
18. Giannini AJ, Price WA, Loiselle RH (1984) B-endorphin withdrawal: a possible cause of premenstrual tension syndrome. Int J Psychophysiol 1: 341-343.
19. Tulenheimo A, Laatikainen T, Salminen K (1987) Plasma Bendorphin immunoreactivity in premenstrual tension. Br J Obstet Gynaecol 94: 26-29.
20. Facchinetti F, Martignoni E, Petraglia F et al (1987) Premenstrual fall of plasma B-endorphin in patients with premenstrual syndrome. Fertil Steril 47: 570-573.
21. Rapkin AJ, Shoupe D, Reading A et al (1996) Decreased central opioid activity in premenstrual syndrome: Luteinizing hormone response to naloxone. J Soc Gynecol Invest 3: 93-98.
22. Lewis LL, Greenblatt EM, Rittenhouse CA et al (1995) Pulsatile release patterns of luteinizing hormone and progesterone in relation to sympton onset in women with premenstrual syndrome. Fertil Steril 64: 288-292.
23. Halbreich U, Piletz JE, Carson S et al (1993) Increased imidazoline and α2 adrenergic binding in platelets of women with dysphoric premenstrual syndromes. Biol Psychiatry 34: 676-686.
24. Gurguis GNA, Yonkers KA, Williams A, Rush AJ (1995) Adrenergic receptor function in premenstrual dysphoric disorder (Abstract #55) Biol Psychiatry 37: 607.
25. Halbreich U, Petty F, Yonkers K et al (1996) Low plasma γ-aminobutyric acid levels during the late luteal phase of women with premenstrual dysphoric disorder. Am J Psychiatry 153: 718-720.
26. Ehrenkranz JRL (1976) Effects of sex steroids on serotonin uptake in blood platelets. Acta Endocrinol 83: 420-428.
27. Rapkin AJ, Edelmuth E, Chang LC et al (1987) Whole-blood serotonin in premenstrual syndrome. Obstet Gynecol 70: 533-537.
28. Ashby CRJ, Carr LA, Cook CL et al (1988) Alteration of platelet serotonergic mechanisms and monoamine oxidase activity in premenstrual syndrome. Biol Psychiatry 24: 225-233.
29. Yatham LN (1993) Is 5HT-la receptor subsensitivity a trait marker for late luteal phase dysphoric disorder? A pilot study. Can J Psychiatry 38: 662-664.
30. Bancroft J, Cook A, Davidson D et al (1991) Blunting of neuroendocrine responses to infusion of L-tryptophan in women with perimenstrual mood change. Psychol Med 21: 305-312.
31. Menkes DB, Coates DC, Fawcett JP (1994) Acute tryptophan depletion aggravates premenstrual syndrome. J Affect Disord 32: 37-44.
32. Steege JF, Stout AL, Knight BS, Nemeroff CB (1992) Reduced platelet tritium-labeled imipramine binding sites in women with premenstrual syndrome. Am J Obstet Gynecol 167: 168-172.
33. Bancroft J, Cook A (1995) The neuroendocrine response to d-fenfluramine in women with premenstrual depression. J Affect Disord 36: 57-64.
34. Halbreich U, Tworek H (1993) Altered serotonergic activity in women with dysphoric premenstrual syndromes. Int J Psychiatry Med 23: 1-27.
35. Deutsch H (1995) The Psychology of Women. New York: Grune: Stratton.
36. Freeman EVV, Schewizer E, Rickeis K (1995) Personality factors in women with premenstrual syndrome. Psychosom Med 57: 453-459.
37. Freeman E, Sondheimer S, Rickels K, Polansky M (1990) Ineffectiveness of progesterone suppository treatment for premenstrual syndrome. JAMA 264: 349-353.
38. Andersch B, Hahn L (1985) Progesterone treatment of premenstrual tension - A double-blind study. J Psychosom Res 29: 489-493.
39. Dennerstein L, Spencer-Gardner C, Gotts G et al (1985) Progesterone and the premenstrual syndrome: a double blind crossover trial. Br Med J 290: 1617-1621.
40. Sampson G (1979) Premenstrual syndrome: A double-blind controlled trial of progesterone and placebo. Br J Psychiatry 135: 209-215.
41. Van der Meer YG, Benedek-Jaszmann LJ, Van-Loenen AC (1983) Effect of high-dose progesterone on the premenstrual syndrome. J Psychosom Obstet Gynaecol 2: 220-222.
42. Baker ER, Best RG, Manfredi RL et al (1995) Reproductive endocrinology. Efficacy of progesterone vaginal suppositories in alleviation of nervous symptoms in patients with premenstrual syndrome. J Assist Reprod Genet 12: 205-209.
43. Jordheim O (1972) The premenstrual syndrome. Acta Obstet Gynecol Scand 51: 77-80.
44. Maddocks S, Hahn P, Moller F, Reid RL (1986) A double-blind placebo-controlled trial of progesterone vaginal suppositories in the treatment of premenstrual syndrome. Am J Obstet Gynecol 154: 573-581.
45. Freeman EW, Rickels K, Sondheimer SJ, Polansky M (1995) A double-blind trial of oral progesterone, alprazolam, and placebo in treatment of severe premenstrual syndrome. JAMA 274: 51-57.
46. Dennerstein L, Morse C, Gotts G et al (1986) Treatment of premenstrual syndrome: A double-blind trial of dydrogesterone. J Affect Disord 11: 199-205.
47. Kerr GD, Day JB, Munday MR et al (1980) Dydrogesterone in the treatment of the premenstrual syndrome. Practitioner 224: 852-855.
48. Williams JGC, Martin AJ, Hulkenberg-Tromp TEML (1983) PMS in four European countries. 2. A double-blind placebo controlled study of dydrogesterone. Br J Sexual Med 10: 8-18.
49. Dhar V, Murphy BEP (1991) Double-blind randomized crossover trial of luteal phase estrogens (Premarin) in the premenstrual syndrome (PMS). Psychoneuroendocrinol 15: 489-493.
50. Magos AL, Brincat M, Studd JWW (1986) Treatment of the premenstrual syndrome by subcutaneous oestradiol implants and cyclical oral norethisterone: Placebo-controlled study. Br Med J 292: 1629-1633.
51. Watson NR, Studd JWW, Savvas M et al (1989) Treatment of severe premenstrual syndrome with oestradiol patches and cyclical oral norethisterone. Lancet ii: 730-732.
52. Graham CA, Sherwin BB (1992) A prospective treatment study of premenstrual symptoms using a triphasic oral contraceptive. J Psychosom Res 36: 257-266.
53. Bancroft J, Rennie D (1993) The impact of oral contraceptives on the experience of perimenstrual mood, clumsiness, food craving and other symptoms. J Psychosom Res 37: 195-202.
54. Backstrom T, Hansson-Malmstrom Y, Lindhe B-A et al (1992) Oral contraceptives in premenstrual syndrome: A randomized comparison of triphasic and monophasic preparations. Contraception 46: 253-268.
55. Yonkers KA (1997) Treatment of premenstrual dysphoric disorder. Curr Rev Mood Disord Anxiety Disord 1: 215-237.
56. Singer K, Cheng R, Schou M (1974) A controlled evaluation of lithium in the premenstrual tension syndrome. Br J Psychiatry 124: 50-51.
57. Schmidt PJ, Grover GN, Rubinow DR (1993) Alprazolam in the treatment of premenstrual syndrome. A double-blind, placebo-controlled trial. Arch Gen Psychiatry 50: 467-473.
58. Smith S, Rinehart JS, Ruddock VE, Schiff I (1987) Treatment of premenstrual syndrome with alprazolam: Results of a double-blind, placebo-controlled, randomized crossover clinical trial. Obsfet Gynecol 70: 37-43.
59. Harrison WM, Endicott J, Nee J (1990) Treatment of premenstrual dysphoria with alprazolam. Arch Gen Psychiatry 47: 270-275.
60. Wood SH, Mortola JF, Chan Yuen F et al (1992) Treatment of premenstrual syndrome with fluoexetine: A double-blind, placebo-controlled, crossover study. Obstet Gynecol 80: 339-344.
61. Steiner M, Steinberg S, Stewart D et al (1995) Fluoxetine in the treatment of premenstrual dysphoria. N Engl J Med 332: 1529-1534.
62. Menkes DB, Taghavi E, Mason PA et al (1992) Fluoxetine treatment of severe premenstrual syndrome. Br Med J 305: 346-347.
63. Stone AB, Pearlstein TB, Brown WA (1991) Fluoxetine in the treatment of late luteal phase dysphoric disorder. J Clin Psychiatry 52: 290-293.
64. Eriksson E, Hedberg MA, Andersch B, Sundblad C (1995) The serotonin reuptake inhibitor paroxetine is superior to the noradrenaline reuptake inhibitor maprotiline in the treatment of premenstrual syndrome. Neuropsychopharmacol 12: 169-176.
65. Yonkers KA, Gullion C, Williams A et al (1996) Paroxetine as a treatment for premenstrual dysphoric disorder. J Clin Psychopharmacol 16: 3-8.
66. Yonkers KA, Halbreich U, Freeman EW et al (1996) Sertraline in the treatment of premenstrual dysphoric disorder. Psychopharmacol Bull 32: 41-46.
67. Rickets K, Freeman E, Sondheimer S (1989) Buspirone in treatment of premenstrual syndrome. Lancet iv: 777.
68. Eriksson E, Lisjo P, Sundblad C et al (1989) Effect of clomipramine on premenstrual syndrome. Acta Psychiatr Scand 81: 87-88.
69. Sundblad C, Hedberg MA, Eriksson E (1993) Clomipramine administered during the luteal phase reduces the symptoms of premenstrual syndrome: A placebo-controlled trial. Neuropsychopharmacol 9: 133-145.
70. Freeman EW, Rickels K, Sondheimer SJ et al (1994) Nefazodone in the treatment of premenstrual syndrome: A preliminary study. J Clin Psychopharmacol 14: 180-186.
71. Brzezinski AA, Wurtman JJ, Wurtman RJ et al (1990) dfenfluramine suppresses the increased calorie and carbohydrate intakes and improves the mood of women with premenstrual depression. Obstet Gynecol 76: 296-300.
72. Steinberg S, Annable L, Young YN, Belanger MC (1994) Tryptophan in the treatment of late luteal phase dysphoric disorder: A pilot study. J Psychiatr Neurosci 19: 114-119.
73. Pearlstein TB, Stone AB, Lund SA et al (1995) A double-blind comparison of fluoexetine, buproprion and placebo in premenstrual dysphoric disorder (Abstract 314) Annual Meeting of the American Psychiatric Association, May 23, Miami, FL.
74. O'Brien PMS, Craven D, Selby C, Symonds EM (1979) Treatment of premenstrual syndrome by spironolactone. Br J Obstet Gynaecol 86: 142-147.
75. Vellacott ID, Shroff NE, Pearce MY et al (1987) A double-blind, placebo-controlled evaluation of spironolactone in the premenstrual syndrome. Curr Med Res Opin 10: 450-456.
76. Mira M, McNeil D, Fraser IS et al (1986) Mefenamic acid in the treatment of premenstrual syndrome. Obstet Cynecol 68: 395-398.
77. Facchinetti F, Fioroni L, Sances G et al (1989) Naproxen sodium in the treatment of premenstrual symptoms. A placebo-controlled study. Gynecol Obstet Invest 28: 205-208.
78. Parry BL, Rosenthal NE, James SP, Wehr TA (1991) Atenolol in premenstrual syndrome: A test of the melatonin hypothesis. Psychiatr Res 37: 131-138.
79. Rausch JL, Janowsky DS, Golshan S et al (1988) Atenolol treatment of late luteal phase dysphoric disorder. J Affect Disord 15: 141-147.
80. Chuong CJ, Hsi BP (1994) Effect of naloxone on luteinizing hormone secretion in premenstrual syndrome. Fertil Steril 61: 1039-1044.
81. Sayegh R, Schiff I, Wurtman J et al (1995) The effect of a carbohydrate-rich beverage on mood, appetite, and cognitive function in women with premenstrual syndrome. Obstet Gynecol 86: 520-528.
82. Abraham GE, Hargrove JT (1980) Effect of vitamin B-6 on premenstrual symptomatology in women with premenstrual tension syndromes: A double blind crossover study. Infertility 3: 155-165.
83. Barr W (1984) Pyridoxine supplements in the premenstrual syndrome. Practitioner 228: 425-427.
84. Pearlstein T, Rivera-Tovar A, Frank E et al (1992) Nonmedical management of late luteal phase dysphoric disorder. J Psychother Pract Res 1: 49-55.
85. Christensen AP, Oei TP (1995) The efficacy of cognitive behaviour therapy in treating premenstrual dysphoric changes. J Affect Disord 33: 57-63.
86. Morse CA, Dennerstein L, Farrell E, Varnavides K (1991) A comparison of hormone therapy, coping skills training, and relaxation for the relief of premenstrual syndrome. J Behav Med 14, 469-489.